Abstract:We report on 11 cases of isochromosome 12p mosaicism (or Pallister mosaic aneuploidy syndrome) in which the isochromosome is usually absent in cultured lymphocytes but present in fibroblasts. The patients range in age from a 22-week-gestation fetus to a 45-year-old man. They have a distinct pattern of anomalies which enables one to make a diagnosis based on clinical manifestations alone. Craniofacial manifestations include "coarse" face with prominent forehead, sparsity of scalp hair, hypertelorism, epicanthal… Show more
“…The distinct phenotype of PKS enables a diagnosis based solely on clinical manifestations in the majority of cases. 3,7 In our patient, the clinical findings were consistent with PKS. Nevertheless, cytogenetic analysis did not reveal the typical finding of supernumerary i(12p) in fibroblasts.…”
Cytogenetic analysis in a girl with multiple congenital anomalies indicating Pallister-Killian syndrome (PKS) showed a supernumerary marker chromosome in 1/76 lymphocytes and 34/75 fibroblast metaphases. GTGbanding pattern was consistent with the chromosomal region 12pter-12q11. While fluorescence-in-situ hybridisation (FISH) with a whole chromosome 12 painting probe confirmed the origin of the marker, a chromosome 12 specific a-satellite probe did not hybridise to it. FISH analysis with a specific subtelomeric probe 12p showed hybridisation to both ends of the marker chromosome. High-resolution multicolour-banding (MCB) studies revealed the marker to be a der(12)(pter?p12.3::p12.3?pter). Summarising the FISH information, we defined the marker as an inverted duplication of 12pter-12p12.3 leading to partial tetrasomy of chromosome 12p. In skin fibroblasts, cultured at the patient's age of 1 year and 9 years, the marker chromosome was found in similar frequencies, even after several culture passages. Therefore, we consider the marker to have a functional centromere although it lacks detectable centromeric a-satellite sequences. To the best of our knowledge, this is the first proven analphoid marker of chromosome 12. Molecular genetic studies indicated that this marker is of paternal origin. The finding of partial tetrasomy 12pter-12p12.3 in our PKS patient allows to narrow down the critical region for PKS. European Journal of Human Genetics (2001) 9, 572 ± 576.
“…The distinct phenotype of PKS enables a diagnosis based solely on clinical manifestations in the majority of cases. 3,7 In our patient, the clinical findings were consistent with PKS. Nevertheless, cytogenetic analysis did not reveal the typical finding of supernumerary i(12p) in fibroblasts.…”
Cytogenetic analysis in a girl with multiple congenital anomalies indicating Pallister-Killian syndrome (PKS) showed a supernumerary marker chromosome in 1/76 lymphocytes and 34/75 fibroblast metaphases. GTGbanding pattern was consistent with the chromosomal region 12pter-12q11. While fluorescence-in-situ hybridisation (FISH) with a whole chromosome 12 painting probe confirmed the origin of the marker, a chromosome 12 specific a-satellite probe did not hybridise to it. FISH analysis with a specific subtelomeric probe 12p showed hybridisation to both ends of the marker chromosome. High-resolution multicolour-banding (MCB) studies revealed the marker to be a der(12)(pter?p12.3::p12.3?pter). Summarising the FISH information, we defined the marker as an inverted duplication of 12pter-12p12.3 leading to partial tetrasomy of chromosome 12p. In skin fibroblasts, cultured at the patient's age of 1 year and 9 years, the marker chromosome was found in similar frequencies, even after several culture passages. Therefore, we consider the marker to have a functional centromere although it lacks detectable centromeric a-satellite sequences. To the best of our knowledge, this is the first proven analphoid marker of chromosome 12. Molecular genetic studies indicated that this marker is of paternal origin. The finding of partial tetrasomy 12pter-12p12.3 in our PKS patient allows to narrow down the critical region for PKS. European Journal of Human Genetics (2001) 9, 572 ± 576.
“…In a number of cases (Lopes et al, 1985;Raffel et al, 1986;Pauli et aI., 1987;Reynolds et al, 1987;Warburton et al, 1987), i(12p) was found in 10-20~ of blood lymphocytes. The percentage of tetrasomy 12p in lymphocytes in our case (43~) was even higher.…”
Section: Discussionmentioning
confidence: 93%
“…It should be noted that tetrasomy 12p mosaicism has been increasingly ascertained at birth or by prenatal diagnosis. Review of autopsy findings in 8 such cases (Gilgenkrantz et aI., 1985;Lopes et al, 1985;Hiraishi et aI., 1987;Pauli et al, 1987;Reynolds et al, 1987;Steinbach and Rehder, 1987;Warburton et al, 1987) showed that internal malformations are not at all rare and lung hypoplasia is a common pathological finding (Table 4). This type of malformation may explain why neonatal asphyxia is frequently associated with Pallister-Killian syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…The similarity of banding patterns between the 12p and 21q has sometimes led to a misinterpretation of i(12p) as i(21q) (Fryns et al, 1982;Hunter et al, 1982;Kwee et aI., 1984;Lopes et al, 1985). More than two dozen of cases have so far been reported (Reynolds et al, 1987). Patients with Pallister-Killian syndrome invariably show characteristic clinical features, including normal intrauterine growth, severe mental retardation, pigmentary dysplasia, aberrant scalp hair pattern in infancy and coarse face (Buyse and Korf, 1983).…”
“…This syndrome (also known as Pallister mosaic aneuploidy syndrome or isochromosome 12p mosaicism) is characterized by postnatal growth retardation, seizures, hypotonia, deafness, profound mental retardation, minimal speech development, and a distinctive facial appearance (high prominent forehead, ocular hypertelorism, sparse anterior scalp hair, prominent lower lip, large ears with thick protruding lobules, cupid-bow shaped upper lip, and a long philtrum) [Pallister et al, 1977;Teschler-Nicola and Killian, 1981;Reynolds et al, 1987;Bergoffen et al, 1993]. A chromosome 12 abnormality (tetrasomy 12p) has been reported in skin biopsies from these patients but this chromosome anomaly is usually not found (or in only a small proportion, e.g., <0.5%, of blood cells) in peripheral blood [Raffel et al, 1986;Warburton et al, 1987;Larramendy et al, 1993;Ohashi et al, 1993].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.